The Vaccine Renaissance: How Big Pharma Profits from Swine Flu
How Big Pharma Profits from Swine Flu By Kerry Capell Once spurned by drugmakers as low-margin and risky, vaccines to fight diseases such as H1N1 are now a growing business for Novartis and others. Swiss pharmaceutical giant...



